Maurizio Rocchetti

2.3k total citations
35 papers, 1.3k citations indexed

About

Maurizio Rocchetti is a scholar working on Molecular Biology, Modeling and Simulation and Oncology. According to data from OpenAlex, Maurizio Rocchetti has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Modeling and Simulation and 7 papers in Oncology. Recurrent topics in Maurizio Rocchetti's work include Mathematical Biology Tumor Growth (9 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Analytical Chemistry and Chromatography (4 papers). Maurizio Rocchetti is often cited by papers focused on Mathematical Biology Tumor Growth (9 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Analytical Chemistry and Chromatography (4 papers). Maurizio Rocchetti collaborates with scholars based in Italy, United States and United Kingdom. Maurizio Rocchetti's co-authors include Giuseppe De Nicolao, Italo Poggesi, Massimiliano Germani, Paolo Magni, Monica Simeoni, Enrico Pesenti, Valter Croci, P. Bettica, Prem Puri and Martino Recchia and has published in prestigious journals such as Blood, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Maurizio Rocchetti

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maurizio Rocchetti Italy 18 615 378 217 137 132 35 1.3k
Monica Simeoni United Kingdom 14 442 0.7× 315 0.8× 258 1.2× 70 0.5× 135 1.0× 28 998
Massimiliano Germani Italy 12 380 0.6× 265 0.7× 225 1.0× 61 0.4× 97 0.7× 24 793
Mirra Chung United States 20 949 1.5× 544 1.4× 33 0.2× 114 0.8× 218 1.7× 29 1.8k
R. Christopher Harmon United States 11 434 0.7× 358 0.9× 18 0.1× 84 0.6× 136 1.0× 13 1.1k
Jin Y. Jin United States 24 538 0.9× 732 1.9× 69 0.3× 11 0.1× 168 1.3× 95 1.9k
Andrew E. Place United States 16 862 1.4× 472 1.2× 13 0.1× 82 0.6× 220 1.7× 55 1.6k
Xuguang Zheng United States 19 1.2k 2.0× 262 0.7× 41 0.2× 87 0.6× 903 6.8× 32 1.8k
Jenny Tan United States 20 1.3k 2.1× 648 1.7× 16 0.1× 111 0.8× 246 1.9× 46 2.5k
Paul Dent United States 19 817 1.3× 521 1.4× 13 0.1× 134 1.0× 170 1.3× 21 1.4k
Xiaoxiao Sun China 24 1.2k 1.9× 408 1.1× 15 0.1× 128 0.9× 317 2.4× 71 2.1k

Countries citing papers authored by Maurizio Rocchetti

Since Specialization
Citations

This map shows the geographic impact of Maurizio Rocchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurizio Rocchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurizio Rocchetti more than expected).

Fields of papers citing papers by Maurizio Rocchetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurizio Rocchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurizio Rocchetti. The network helps show where Maurizio Rocchetti may publish in the future.

Co-authorship network of co-authors of Maurizio Rocchetti

This figure shows the co-authorship network connecting the top 25 collaborators of Maurizio Rocchetti. A scholar is included among the top collaborators of Maurizio Rocchetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurizio Rocchetti. Maurizio Rocchetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartolucci, Roberta, et al.. (2024). In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients. CPT Pharmacometrics & Systems Pharmacology. 13(3). 359–373. 6 indexed citations
2.
Rocchetti, Maurizio, et al.. (2019). A Tumor-in-Host DEB-Based Approach for Modeling Cachexia and Bevacizumab Resistance. Cancer Research. 80(4). 820–831. 14 indexed citations
3.
Bettica, P., Stefania Petrini, Valentina Doria, et al.. (2016). Histological effects of givinostat in boys with Duchenne muscular dystrophy. Neuromuscular Disorders. 26(10). 643–649. 141 indexed citations
4.
Rocchetti, Maurizio, Massimiliano Germani, Italo Poggesi, et al.. (2013). Predictive pharmacokinetic–pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts. Cancer Chemotherapy and Pharmacology. 71(5). 1147–1157. 27 indexed citations
5.
Simeoni, Monica, Giuseppe De Nicolao, Paolo Magni, Maurizio Rocchetti, & Italo Poggesi. (2012). Modeling of human tumor xenografts and dose rationale in oncology. Drug Discovery Today Technologies. 10(3). e365–e372. 31 indexed citations
6.
Cohen, Roger B., Suzanne F. Jones, Charu Aggarwal, et al.. (2009). A Phase I Dose-Escalation Study of Danusertib (PHA-739358) Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors. Clinical Cancer Research. 15(21). 6694–6701. 78 indexed citations
7.
Magni, Paolo, Massimiliano Germani, Giuseppe De Nicolao, et al.. (2008). A Minimal Model of Tumor Growth Inhibition. IEEE Transactions on Biomedical Engineering. 55(12). 2683–2690. 21 indexed citations
8.
Germani, Massimiliano, et al.. (2008). A model-based approach to the in vitro evaluation of anticancer activity. Cancer Chemotherapy and Pharmacology. 63(5). 827–836. 20 indexed citations
9.
Crivori, Patrizia, et al.. (2007). Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems. European Journal of Pharmaceutical Sciences. 32(3). 169–181. 7 indexed citations
10.
Germani, Massimiliano, Patrizia Crivori, Maurizio Rocchetti, et al.. (2007). Evaluation of a basic physiologically based pharmacokinetic model for simulating the first-time-in-animal study. European Journal of Pharmaceutical Sciences. 31(3-4). 190–201. 25 indexed citations
11.
Paquette, Ronald, Neil P. Shah, Charles L. Sawyers, et al.. (2007). PHA-739358, an Aurora Kinase Inhibitor, Induces Clinical Responses in Chronic Myeloid Leukemia Harboring T315I Mutations of BCR-ABL.. Blood. 110(11). 1030–1030. 44 indexed citations
12.
Germani, Massimiliano, Patrizia Crivori, Maurizio Rocchetti, et al.. (2005). Evaluation of a Physiologically‐Based Pharmacokinetic Approach for Simulating the First‐Time‐In‐Animal Study. Basic & Clinical Pharmacology & Toxicology. 96(3). 254–256. 5 indexed citations
13.
Poggesi, Italo, et al.. (2004). The effects of degree of hepatic or renal impairment on the pharmacokinetics of exemestane in postmenopausal women. Cancer Chemotherapy and Pharmacology. 53(6). 475–481. 20 indexed citations
14.
Simeoni, Monica, Paolo Magni, Giuseppe De Nicolao, et al.. (2004). Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents. Cancer Research. 64(3). 1094–1101. 373 indexed citations
15.
Germani, Massimiliano, Paolo Magni, Giuseppe De Nicolao, et al.. (2003). In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time. Cancer Chemotherapy and Pharmacology. 52(6). 507–513. 8 indexed citations
16.
Latini, Roberto, et al.. (1994). Effects of lisinopril and nitroglycerin on blood pressure early after myocardial infarction: The GISSI-3 pilot study. Clinical Pharmacology & Therapeutics. 56(6). 680–692. 7 indexed citations
17.
Imbimbo, Bruno P., et al.. (1991). Efficiency of different criteria for selecting pharmacokinetic multiexponential equations. Biopharmaceutics & Drug Disposition. 12(2). 139–147. 30 indexed citations
18.
Guardabasso, Vincenzo, et al.. (1990). The relationship between rate of venous sampling and visible frequency of hormone pulses. Computer Methods and Programs in Biomedicine. 33(3). 145–157. 3 indexed citations
19.
Rocchetti, Maurizio, et al.. (1983). Mathematical Modelling of Growth Kinetics of Walker 256 Carcinoma in Rats. Oncology. 40(2). 143–147. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Simeoni Breakdown of academic impact, for papers by Massimiliano Germani Breakdown of academic impact, for papers by Mirra Chung Breakdown of academic impact, for papers by R. Christopher Harmon Breakdown of academic impact, for papers by Jin Y. Jin Breakdown of academic impact, for papers by Andrew E. Place Breakdown of academic impact, for papers by Xuguang Zheng Breakdown of academic impact, for papers by Jenny Tan Breakdown of academic impact, for papers by Paul Dent Breakdown of academic impact, for papers by Xiaoxiao Sun
Rankless by CCL
2026